Ross Edmund Burke Jr. 4
4 · AzurRx BioPharma, Inc. · Filed Jan 7, 2019
Insider Transaction Report
Form 4
Ross Edmund Burke Jr.
10% Owner
Transactions
- Purchase
Common Stock
2018-05-02$2.50/sh+20,000$50,000→ 2,421,010 total(indirect: See Footnote) - Purchase
Common Stock
2018-12-27$1.18/sh+42,922$50,648→ 2,463,932 total(indirect: See Footnote) - Purchase
Common Stock
2018-12-27$1.13/sh+23,200$26,216→ 2,487,132 total(indirect: See Footnote) - Purchase
Common Stock
2018-12-28$1.18/sh+29,575$34,899→ 2,516,707 total(indirect: See Footnote) - Purchase
Common Stock
2018-12-31$1.12/sh+23,848$26,710→ 2,540,555 total(indirect: See Footnote)
Footnotes (5)
- [F1]Mr. Ross is the manager and holds sole voting and dispositive power over the shares of common stock and each of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, and CEDA Investments, LLC disclaims beneficial ownership of such securities underlying the warrants, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that any of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, or CEDA Investments, LLC is the beneficial owner of such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Mr. Ross disclaims beneficial ownership of the securities described in this footnote except to the extent of his pecuniary interest.
- [F2]Of the aggregate number of shares purchased on May 2, 2018, CEDA Investments, LLC purchased all 20,000 shares.
- [F3]Of the aggregate number of shares purchased on December 27, 2018, EBR Ventures, LLC purchased all 66,122 shares.
- [F4]Of the aggregate number of shares purchased on December 28, 2018, EBR Ventures, LLC purchased all 29,575 shares.
- [F5]Of the aggregate number of shares purchased on December 31, 2018, EBR Ventures, LLC purchased all 23,848 shares.